Page 136 - Read Online
P. 136
Hershman. J Cancer Metastasis Treat 2022;8:3 https://dx.doi.org/10.20517/2394-4722.2021.156 Page 3 of 3
4. Nagayama Y. Autophagy and thyroid cancer. J Cancer Metastasis Treat 2021;7:6. DOI
5. Lee WK, Cheng SY. Targeting transcriptional regulators for treatment of anaplastic thyroid cancer. J Cancer Metastasis Treat
2021;7:27. DOI
18
6. Quartuccio N, Rubello D. Role of F-FDG PET/CT in detection of hematogenous metastases of advanced differentiated thyroid
carcinoma: a systematic review and meta-analysis. J Cancer Metastasis Treat 2021;7:14. DOI
7. Corn S, Mitmaker E, Tabar R, Ciarallo A, How J. Incidental thyroid uptake on PET scanning: epidemiology, clinical significance, and
management challenge. J Cancer Metastasis Treat 2021;7:41. DOI
8. Matrone A, Gambale C, Prete A, et al. Systemic treatment of advanced, metastatic, medullary thyroid carcinoma. J Cancer Metastasis
Treat 2021;7:23. DOI
9. Izkhakov E, Keinan-boker L, Stern N. Cardiovascular morbidity and mortality as a confounder of prognosis in thyroid cancer. J
Cancer Metastasis Treat 2021;7:24. DOI
10. Priya S, Garg S, Dandekar M. Intraoperative monitoring of the recurrent laryngeal nerve in surgeries for thyroid cancer: a review. J
Cancer Metastasis Treat 2021;7:70. DOI